Biovet's new vax developed to treat skin disease of livestock gets regulator's license

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle and buffaloes. Developed with the DIVA concept, it ensures high safety and efficacy while distinguishing between infected and vaccinated animals, a crucial step toward India's self-reliance in veterinary healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LvRHWDG
via IFTTT